# Sources — Frederick Law Olmsted

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 3, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Wikipedia. “Frederick Law Olmsted.” Supports his birth in Hartford, Connecticut, on April 26, 1822; his death in Belmont, Massachusetts, on August 28, 1903, at 81; his resignation from the U.S. Sanitary Commission in 1863, exhausted and ill; that senility forced him to retire in 1895 (a sentence without a footnote, corroborated by sources 2 and 5); and that by 1898 he was a patient at McLean Hospital, where he remained until his death. https://en.wikipedia.org/wiki/Frederick_Law_Olmsted
2. Olmsted Network. “The Olmsted Firm.” Supports that he ceased active practice in 1895, “a victim of failing memory and vitality,” and that his son took his place in the firm. https://olmsted.org/the-olmsted-firm/
3. National Park Service. “Felsted” (last updated June 5, 2024). Supports his deteriorating health; an earlier trip to England that did not help and during which he became depressed; the summer house on Deer Isle, Maine, laid out in 1897 to stimulate his decreasing mental abilities; one summer there with continued decline; his commitment to McLean Hospital, where he spent the rest of his life; and his death in 1903. https://www.nps.gov/places/felsted.htm
4. National Park Service. “McLean Asylum” (last updated July 18, 2025). Supports his choice of the hospital’s Belmont site in 1872 and his return there at the end of his life as a patient. https://www.nps.gov/places/mclean-asylum.htm
5. Porter-Brown N. “Where Frederick Law Olmsted lived his last good years.” *Harvard Magazine*, August 15, 2014. Supports that his sons took over the firm when dementia forced his retirement and that he spent the last five years of his life at McLean Hospital. https://www.harvardmagazine.com/2014/09/a-park-of-ones-own
6. Sperber M. “Frederick Law Olmsted.” *Harvard Magazine*, July 1, 2007. A psychiatrist’s profile. Supports that he was hospitalized at McLean for the last five years of his life and that his medical record is sealed; offers the retrospective interpretation that childhood losses left him with post-traumatic stress that his late illness made worse. https://www.harvardmagazine.com/2007/07/frederick-law-olmsted-html
7. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), Non-Alzheimer’s dementia and Alzheimer’s disease monographs. Every visit: Beers Criteria medication review, neuropsychiatric screen (NPI-Q), vascular risk-factor control, home safety, cholinesterase inhibitor tolerability, antipsychotic review if on one. At diagnosis: TSH and vitamin B12, blood count and metabolic panel, one non-contrast MRI. Annually: MoCA, ADL and IADL, CDR or FAST stage, depression screen, fall risk, driving, advance care planning. Every 6 to 12 months: Zarit Burden Interview. Biomarkers, APOE, and ARIA MRI only with anti-amyloid therapy. https://patrickrutledge.github.io/topthirty/
2. Knopman DS et al. Practice parameter: diagnosis of dementia. American Academy of Neurology, *Neurology* 2001 (reaffirmed, per the CMID). Vitamin B12 and thyroid testing, structural imaging, depression screening; syphilis testing only with risk factors. https://pubmed.ncbi.nlm.nih.gov/11342678/
3. Iverson DJ et al. Practice parameter update: evaluation and management of driving risk in dementia. American Academy of Neurology, *Neurology* 2010. CDR-based driving risk. https://pubmed.ncbi.nlm.nih.gov/20385882/
4. Atri A et al. Alzheimer’s Association clinical practice guideline (DETeCD-ADRD): executive summary of recommendations for primary care. *Alzheimer’s & Dementia* 2025. https://pubmed.ncbi.nlm.nih.gov/39713942/
5. Dickerson BC et al. Alzheimer’s Association clinical practice guideline (DETeCD-ADRD): executive summary of recommendations for specialty care. *Alzheimer’s & Dementia* 2025. Biomarker testing, disclosure, and counseling. https://pubmed.ncbi.nlm.nih.gov/39713957/
6. American Geriatrics Society. 2023 Updated AGS Beers Criteria. *Journal of the American Geriatrics Society* 2023. Anticholinergic drugs, first-generation antihistamines, benzodiazepines, and sleeping pills to avoid in dementia. https://doi.org/10.1111/jgs.18372
7. Harris AM et al. Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults. American College of Physicians and CDC, *Annals of Internal Medicine* 2016. https://pubmed.ncbi.nlm.nih.gov/26785402/
8. Centers for Medicare & Medicaid Services. Medicare Wellness Visits. https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html
9. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/
10. U.S. Preventive Services Task Force: A and B recommendations; colorectal cancer screening (2021); hepatitis C screening (2020); statin use for primary prevention (2022); prostate cancer screening (2018); cognitive impairment screening (2020); falls prevention in older adults (2024). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
11. Centers for Disease Control and Prevention. Adult Immunization Schedule by Age. https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html

## Editorial resolutions

- **Dementia and its cause.** The failing memory that ended his practice in 1895, the continued decline, and his last five years at McLean Hospital are documented (**D**). The cause is not known, and his McLean record is sealed. The sources say only failing memory, senility, and dementia, so any specific type, such as Alzheimer’s disease or vascular dementia, is graded **R** (certainty possible) and is not coded. The modern record codes unspecified mild dementia (F03.A0), and the synthetic workup is designed to leave the type undetermined: normal reversible-cause tests, a nonspecific MRI, and biomarker testing declined by the patient.
- **Caregivers and real people.** No statement, decision, or health fact is attributed to his wife, sons, or business partners. The episode has one primary caregiver, who is not named and whose relationship to him is not stated, and “family” appears only in general terms. The caregiver’s Zarit score, sleep, and use of an adult day program are synthetic. The documented decisions about his care in the 1890s (the trip to England, the Maine house, the admission to McLean) are recorded only as claims, worded without attributing them to a named person.
- **Index age.** The modern episode presents Olmsted at 73, in the year failing memory ended his practice. The synthetic date of birth is April 26, 1953 (shift 131 years). The index visit on May 5, 2026 maps to May 5, 1895; the chronic-care visits on June 2, August 4, and October 27, 2026 map to the same days of 1895; the sick visit on July 14, 2026 maps to July 14, 1895; and the annual wellness visit on September 15, 2026 maps to September 15, 1895. The fetched sources do not date his trip to England or other movements within 1895, so the visits are not checked against them. Past medical history includes only the 1863 illness; the later decline and the McLean years are claims only.
- **Synthetic clinical picture.** The amnestic decline with loss of ability to manage his work and affairs is anchored to the documented failing memory. The MoCA (19), CDR 1, FAST 4, ADL and IADL scores, NPI-Q, PHQ-9 scores (6 and 4), laboratory results, MRI findings, donepezil trial, and safety measures are synthetic. The PHQ-9 is kept below 10 with no thoughts of self-harm, so no safety assessment is required (the dementia code F03.A0 does not trigger it); his documented depression during the later trip to England is a claim only, marked sensitive. Katz ADL, Lawton-Brody IADL, CDR, FAST, NPI-Q, the Zarit Burden Interview, the 4AT, and Timed Up and Go have no verified LOINC code (or none used) and are recorded as narrative.
- **Modern anachronisms.** Driving, firearms, and over-the-counter cold medicines belong to the modern frame of the episode and make no claim about his life.
- **Sick visit.** A same-day sick visit on July 14, 2026 records a common cold (J00) with two nights of confusion after an over-the-counter nighttime cold medicine containing diphenhydramine. It was chosen to teach the anticholinergic hazard in dementia and its interaction with donepezil, and the 4AT (score 1, from baseline disorientation to the year, below the delirium range). It does not echo a documented illness.
- **Annual wellness visit.** A subsequent annual wellness visit (age 73, so `annual_wellness_subsequent`) on September 15, 2026. Judgment calls: (1) cognition is assessed by direct observation and the established diagnosis, with the MoCA kept on the yearly dementia schedule; (2) the health risk assessment is answered by him with caregiver help; (3) the statin decision follows the USPSTF criteria (risk about 18 percent from age alone, with no risk factor), and he declines a statin; (4) the stool test and hepatitis C test are ordered with no results recorded; (5) advance care planning was done at the three-month visit and is reviewed here; only general values are recorded (staying at home among gardens and trees as long as safe, being told the truth), with no treatment preference.
- **Focused visits.** The three chronic-care follow-ups (four weeks, three months, and about six months after the first visit) are documented as focused visits on the CMID non-Alzheimer’s dementia and Alzheimer’s disease monographs, with the AAN parameters and the Alzheimer’s Association guideline. Each lists every item the protocol calls for at that point, with its interval and status. The four-week visit is the same day as the behavioral neurology consultation. Protocol deviations recorded instead of invented results: (1) the Zarit Burden Interview was not done at the diagnosis visit and was done at three months (24, moderate burden), with no caregiver crisis in between; (2) the home safety checklist was not reviewed at the three-month visit and was completed at six months, with no falls, burns, or wandering in between. Syphilis and HIV testing, biomarkers, anti-amyloid therapy, and antipsychotic review are recorded as not indicated, with the reason.
- **Consultation.** The behavioral neurology referral and the consultation by Marguerite Osei, MD (a fictional consultant), on the day of the four-week visit, are **S**. The consultant answers the six referral questions with what the record shows happened afterwards: mild dementia (CDR 1) rather than mild cognitive impairment, type undetermined with Alzheimer’s disease most likely, biomarkers and anti-amyloid therapy discussed and declined by the patient, donepezil 5 mg then 10 mg with pulse and side-effect checks, driving stopped, home, firearm, wandering, and financial safety, caregiver support, early advance care planning, and three-monthly primary care follow-up. The examination adds only normal findings needed to weigh the dementia types (eye movements, tone, reflexes, gait), consistent with Dr. Calder’s same-day note.
- **Not used.** His mother’s death in his early childhood and its reported cause, the retrospective post-traumatic stress interpretation (recorded as an R claim only, marked sensitive), the details of his care at McLean, the cause of his death, and remarks attributed to him on arriving at McLean were not used in the episode. No family history is recorded, because no fetched source documents dementia in a relative. His height is not recorded in a fetched source; the 175 cm in the record is synthetic.
- **Presenting concern.** The intake documents list the presenting concern (PRB-003) rather than the dementia, which is recorded from the four-week visit and consultation. The presenting-concern problem is synthetic (**S**); it is resolved, superseded by the diagnosis, from that visit on.
